SAD Study of CGB3002 in Healthy Participants
Abroad (travel likely)RecruitingPHASE1
Conditions
Alzheimer s Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Nucleus Network, Melbourne, Victoria, Australia
Contact: Study coordinator (Nucleus Network Melbourne) · melbourne@nucleusnetwork.com · 1800 243 733
Study leads
Zhizheng Zhang, M.D.
Study Director
ChainGen Biopharma Ltd